GlassScriptPhysician profile
Deepika Ratnala
NPI 1396368874
$6,204.06
in general payments reported to CMS, 2019-2025
20 companies · $2,537 in 2025
The $2,537 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $488 · 2023: $1,124 · 2024: $1,920 · 2025: $2,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,098 · Food and Beverage: $2,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,098.18 |
| Food and Beverage | $2,482.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $1,472.57 | 2024 | |
| Boston Scientific Corporation | $894.74 | 2024-2025 | Varithena Administration Pack |
| Paragon 28, INC. | $626.38 | 2025 | Portfolio |
| Linvatec Corporation | $611.25 | 2025 | Biobrace 23mm, Quantum, Colink Afx |
| Musculoskeletal Transplant Foundation INC. | $574.80 | 2023 | |
| Nalu Medical, INC. | $316.18 | 2021-2022 | |
| Organogenesis INC. | $244.10 | 2024-2025 | Apligraf, Puraply Wound Matrix |
| Stryker Corporation | $212.92 | 2025 | Salvation, N/A |
| Biotissue Holdings INC. | $212.66 | 2022-2023 | |
| Kci USA, INC. | $189.16 | 2022 | |
| Integra Lifesciences Corporation | $154.62 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Next Science LLC | $149.56 | 2023-2024 | Surgx, Blastx, Xperience |
| Vaporox, INC. | $139.07 | 2023 | Vht-200 Wound Treatment System |
| Biocomposites INC | $135.81 | 2023 | Stimulan |
| Amgen INC. | $84.85 | 2024-2025 | Krystexxa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $50.34 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $46.21 | 2024 | Venclose Maven Catheter |
| Paratek Pharmaceuticals, INC. | $41.99 | 2023 | Nuzyra |
| Solventum Corporation | $25.41 | 2025 | V.A.C. Dermatac, Activ.A.C., Promogran |
| Smith+Nephew, INC. | $21.44 | 2023 | Regranex, Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepika Ratnala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.